Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line-Reference-Cited by-同舟云学术

Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line

Published:2013-04 Issue:4 Volume:101 Page:213-220
ISSN:0888-7543
Container-title:Genomics
language:en
Short-container-title:Genomics

Author:

AbuHammad Shatha,Zihlif Malek

Publisher

Elsevier BV

Subject

Genetics

Reference50 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int. J. Cancer,2010

2. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity;Minotti;Pharmacol. Rev.,2004

3. Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance;Sinha;Cancer Res.,1989

4. BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells;Tassone;Br. J. Cancer,2003

5. TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancer;Villman;Acta Oncol.,2006

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating key genes and biological pathways for therapeutic drug compound identification and survival analysis of chronic lymphocytic leukemia and hepatitis B associated hepatocellular carcinoma using system biology approach;Network Modeling Analysis in Health Informatics and Bioinformatics;2024-08-24

2. Combination of resveratrol and piperine to target doxorubicin resistance in breast cancer: An in vitro and in vivo study;Pharmacia;2024-08-22

3. Failure to progress: breast and prostate cancer cell lines in developing targeted therapies;Cancer and Metastasis Reviews;2024-07-26

4. Silencing of lncRNA UCA1 Reverses Doxorubicin Resistance of Breast Cancer Through Inhibiting PI3K/AKT/mTOR Signaling Pathway;ChemistrySelect;2024-05-24

5. Insights into molecular mechanisms of chemotherapy resistance in cancer;Translational Oncology;2024-04